LG Pharma S.A. is a company listed on the NewConnect market organized by the Warsaw Stock Exchange SA GLG Pharma S.A. is a subsidiary of GLG Pharma LLC with its registered office in the United States of America. The main scope of GLG's activity is research and development in the field of biotechnology. The company has an exclusive worldwide license for the development, manufacture and sale of pharmaceutical products based on STAT3 inhibitors technology, developed by researchers at the Boston Cancer Institute and the Moffitt Cancer Research Center.
Headquarters
Ul. Dunska 9
Wroclaw; Dolnoslaskie;
Postal Code: 54-427
Contact Details: Purchase the "Glg Pharma S.A." report to view the information.
Website: http://www.glgpharma.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service